Trial Outcomes & Findings for The Effect of EGD Probe Insertion on the Intracuff Pressure of the Laryngeal Mask Airway or Cuffed Endotracheal Tube in Children (NCT NCT02645019)

NCT ID: NCT02645019

Last Updated: 2023-06-15

Results Overview

Intracuff pressure in cmH2O of cuffed ETT or LMA during EGD probe insertion.

Recruitment status

COMPLETED

Target enrollment

100 participants

Primary outcome timeframe

At time of EGD probe insertion

Results posted on

2023-06-15

Participant Flow

Participant milestones

Participant milestones
Measure
Cuffed ETT
Airway secured using a cuffed endotracheal tube.
LMA 2
Airway secured using a size 2 laryngeal mask airway.
LMA 2.5
Airway secured using a size 2.5 laryngeal mask airway.
LMA 3
Airway secured using a size 3 laryngeal mask airway.
LMA 4
Airway secured using a size 4 laryngeal mask airway.
Overall Study
STARTED
13
15
15
33
24
Overall Study
COMPLETED
13
15
15
33
24
Overall Study
NOT COMPLETED
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Number of participants analyzed in each row is number that received each type of airway.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LMA 2
n=15 Participants
Airway secured using a size 2 laryngeal mask airway.
LMA 2.5
n=15 Participants
Airway secured using a size 2.5 laryngeal mask airway.
LMA 3
n=33 Participants
Airway secured using a size 3 laryngeal mask airway.
LMA 4
n=24 Participants
Airway secured using a size 4 laryngeal mask airway.
Cuffed ETT
n=13 Participants
Airway secured using a cuffed endotracheal tube.
Total
n=100 Participants
Total of all reporting groups
Age, Categorical
<=18 years
15 Participants
n=5 Participants
15 Participants
n=7 Participants
33 Participants
n=5 Participants
24 Participants
n=4 Participants
13 Participants
n=21 Participants
100 Participants
n=8 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
0 Participants
n=8 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
7 Participants
n=7 Participants
19 Participants
n=5 Participants
10 Participants
n=4 Participants
7 Participants
n=21 Participants
52 Participants
n=8 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
8 Participants
n=7 Participants
14 Participants
n=5 Participants
14 Participants
n=4 Participants
6 Participants
n=21 Participants
48 Participants
n=8 Participants
Intracuff pressure immediately following intubation
15 cmH2O
STANDARD_DEVIATION 13 • n=5 Participants • Number of participants analyzed in each row is number that received each type of airway.
25 cmH2O
STANDARD_DEVIATION 10 • n=7 Participants • Number of participants analyzed in each row is number that received each type of airway.
34 cmH2O
STANDARD_DEVIATION 10 • n=5 Participants • Number of participants analyzed in each row is number that received each type of airway.
32 cmH2O
STANDARD_DEVIATION 10 • n=4 Participants • Number of participants analyzed in each row is number that received each type of airway.
19 cmH2O
STANDARD_DEVIATION 26 • n=21 Participants • Number of participants analyzed in each row is number that received each type of airway.
27 cmH2O
STANDARD_DEVIATION 15 • n=8 Participants • Number of participants analyzed in each row is number that received each type of airway.

PRIMARY outcome

Timeframe: At time of EGD probe insertion

Population: Number of participants that received each type of airway.

Intracuff pressure in cmH2O of cuffed ETT or LMA during EGD probe insertion.

Outcome measures

Outcome measures
Measure
LMA 2
n=15 Participants
Airway secured using a size 2 laryngeal mask airway.
LMA 2.5
n=15 Participants
Airway secured using a size 2.5 laryngeal mask airway.
LMA 3
n=33 Participants
Airway secured using a size 3 laryngeal mask airway.
LMA 4
n=24 Participants
Airway secured using a size 4 laryngeal mask airway.
Cuffed ETT
n=13 Participants
Airway secured using a cuffed endotracheal tube.
Intracuff Pressures During Probe Insertion
22 cmH2O
Standard Deviation 14
34 cmH2O
Standard Deviation 9
41 cmH2O
Standard Deviation 15
37 cmH2O
Standard Deviation 12
24 cmH2O
Standard Deviation 25

PRIMARY outcome

Timeframe: At time of EGD while probe is in place

Population: Number of participants analyzed in each row is number that received each type of airway.

Intracuff pressure in cmH2O of cuffed ETT or LMA during EGD while probe is in place.

Outcome measures

Outcome measures
Measure
LMA 2
n=15 Participants
Airway secured using a size 2 laryngeal mask airway.
LMA 2.5
n=15 Participants
Airway secured using a size 2.5 laryngeal mask airway.
LMA 3
n=33 Participants
Airway secured using a size 3 laryngeal mask airway.
LMA 4
n=24 Participants
Airway secured using a size 4 laryngeal mask airway.
Cuffed ETT
n=13 Participants
Airway secured using a cuffed endotracheal tube.
Intracuff Pressure With Probe in Place
22 cmH2O
Standard Deviation 14
35 cmH2O
Standard Deviation 9
39 cmH2O
Standard Deviation 13
36 cmH2O
Standard Deviation 11
24 cmH2O
Standard Deviation 25

PRIMARY outcome

Timeframe: Immediately after probe removal

Population: Number of participants analyzed in each row is number that received each type of airway.

Intracuff pressure in cmH2O of cuffed ETT or LMA after EGD probe is removed.

Outcome measures

Outcome measures
Measure
LMA 2
n=15 Participants
Airway secured using a size 2 laryngeal mask airway.
LMA 2.5
n=15 Participants
Airway secured using a size 2.5 laryngeal mask airway.
LMA 3
n=33 Participants
Airway secured using a size 3 laryngeal mask airway.
LMA 4
n=24 Participants
Airway secured using a size 4 laryngeal mask airway.
Cuffed ETT
n=13 Participants
Airway secured using a cuffed endotracheal tube.
Intracuff Pressure After Probe Removal
15 cmH2O
Standard Deviation 11
26 cmH2O
Standard Deviation 10
31 cmH2O
Standard Deviation 11
29 cmH2O
Standard Deviation 10
21 cmH2O
Standard Deviation 25

Adverse Events

LMA 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LMA 2.5

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LMA 3

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LMA 4

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Cuffed ETT

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mineto Kamada

Nationwide Children's Hospital

Phone: 6147224200

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place